Skip to main content
Erschienen in: Clinical Journal of Gastroenterology 1/2021

20.09.2020 | Case Report

Collision of a pancreatic ductal adenocarcinoma and a pancreatic neuroendocrine tumor associated with multiple endocrine neoplasm type 1

verfasst von: Akihisa Ohno, Nao Fujimori, Masami Miki, Takamasa Oono, Hisato Igarashi, Ryota Matsuda, Yutaka Koga, Yoshinao Oda, Takao Ohtsuka, Masafumi Nakamura, Tetsuhide Ito, Yoshihiro Ogawa

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

A 54-year-old man with pancreatic head tumor had undergone pancreaticoduodenectomy and was diagnosed with pancreatic neuroendocrine tumor (P-NET) associated with sporadic multiple endocrine neoplasm type 1. Five years after the resection, P-NET recurred and liver metastases were observed. He was treated with a somatostatin analog. Eleven years after the resection, computed tomography revealed a new pancreatic hypodense and hypovascular mass adjacent to the P-NET that was diagnosed as pancreatic adenocarcinoma via endoscopic ultrasound-guided fine-needle aspiration. He underwent a total remnant pancreatectomy. Pathological examination showed that the lesion was constituted by a pancreatic ductal adenocarcinoma (PDAC) and a neuroendocrine tumor. Additionally, the invasive ductal carcinoma collided with the neuroendocrine tumor. Both PDAC and P-NET cells were observed in the collision area. We could observe the onset of PDAC during the treatment of P-NET. Moreover, we are the first to report the case of a collision of pancreatic endocrine and exocrine tumors diagnosed preoperatively.
Literatur
1.
Zurück zum Zitat Chatelain D, Parc Y, Christin-Maitre S, et al. Mixed ductal-pancreatic polypeptide-cell carcinoma of the pancreas. Histopathology. 2002;41:122–6.CrossRef Chatelain D, Parc Y, Christin-Maitre S, et al. Mixed ductal-pancreatic polypeptide-cell carcinoma of the pancreas. Histopathology. 2002;41:122–6.CrossRef
2.
Zurück zum Zitat Klöppel G, Couvelard A, Hruban RH, et al. Neoplasms of the neuroendocrine pancreas. In: Lloyd RV, Osamura RY, Klöppel G, et al., editors. WHO classification of tumours of the endocrine organs. 4th ed. Lyon: IARC Press; 2017. p. 209–240. Klöppel G, Couvelard A, Hruban RH, et al. Neoplasms of the neuroendocrine pancreas. In: Lloyd RV, Osamura RY, Klöppel G, et al., editors. WHO classification of tumours of the endocrine organs. 4th ed. Lyon: IARC Press; 2017. p. 209–240.
3.
Zurück zum Zitat Fukushima N, Hruban RH, Kato Y, et al. Ductal adenocarcinoma variants and mixed neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, et al., editors. World Health Organization classification of tumors of the digestive system. Lyon: IARC Press; 2010. p. 292–295. Fukushima N, Hruban RH, Kato Y, et al. Ductal adenocarcinoma variants and mixed neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, et al., editors. World Health Organization classification of tumors of the digestive system. Lyon: IARC Press; 2010. p. 292–295.
4.
Zurück zum Zitat Niu GM, Jin DY, Ji Y, et al. Survival analysis of pancreatic and periampullary collision cancers. J Dig Dis. 2010;11:231–6.PubMed Niu GM, Jin DY, Ji Y, et al. Survival analysis of pancreatic and periampullary collision cancers. J Dig Dis. 2010;11:231–6.PubMed
6.
Zurück zum Zitat Mori H, Hanada K, Minami T, et al. A case of mixed adenoneuroendocrine carcinoma of the pancreas mimicking intraductal papillary mucinous carcinoma. Clin J Gastroenterol. 2018;11:320–6.CrossRef Mori H, Hanada K, Minami T, et al. A case of mixed adenoneuroendocrine carcinoma of the pancreas mimicking intraductal papillary mucinous carcinoma. Clin J Gastroenterol. 2018;11:320–6.CrossRef
7.
Zurück zum Zitat Imaoka K, Fukuda S, Tazawa H, et al. A mixed adenoneuroendocrine carcinoma of the pancreas: a case report. Surg Case Rep. 2016;2:133.CrossRef Imaoka K, Fukuda S, Tazawa H, et al. A mixed adenoneuroendocrine carcinoma of the pancreas: a case report. Surg Case Rep. 2016;2:133.CrossRef
8.
Zurück zum Zitat Kim HJ, Choi BG, Kim CY, et al. Collision tumor of the ampulla of Vater: coexistence of neuroendocrine carcinoma and adenocarcinoma: report of a case. Korean J Hepatobiliary Pancreat Surg. 2013;17:186–90.CrossRef Kim HJ, Choi BG, Kim CY, et al. Collision tumor of the ampulla of Vater: coexistence of neuroendocrine carcinoma and adenocarcinoma: report of a case. Korean J Hepatobiliary Pancreat Surg. 2013;17:186–90.CrossRef
9.
Zurück zum Zitat Serafini S, Da Dalt G, Pozza G, et al. Collision of ductal adenocarcinoma and neuroendocrine tumor of the pancreas: a case report and review of the literature. World J Surg Oncol. 2017;15:93.CrossRef Serafini S, Da Dalt G, Pozza G, et al. Collision of ductal adenocarcinoma and neuroendocrine tumor of the pancreas: a case report and review of the literature. World J Surg Oncol. 2017;15:93.CrossRef
10.
Zurück zum Zitat Wang Y, Gandhi S, Basu A, et al. Pancreatic collision tumor of ductal adenocarcinoma and neuroendocrine tumor. ACG Case Rep J. 2018;5:e39.CrossRef Wang Y, Gandhi S, Basu A, et al. Pancreatic collision tumor of ductal adenocarcinoma and neuroendocrine tumor. ACG Case Rep J. 2018;5:e39.CrossRef
11.
Zurück zum Zitat Moriyoshi K, Minamiguchi S, Miyagawa-Hayashino A, et al. Collision of extensive exocrine and neuroendocrine neoplasms in multiple endocrine neoplasia type 1 revealed by cytogenetic analysis of loss of heterozygosity: a case report. Pathol Int. 2013;63:469–75.PubMed Moriyoshi K, Minamiguchi S, Miyagawa-Hayashino A, et al. Collision of extensive exocrine and neuroendocrine neoplasms in multiple endocrine neoplasia type 1 revealed by cytogenetic analysis of loss of heterozygosity: a case report. Pathol Int. 2013;63:469–75.PubMed
12.
Zurück zum Zitat Chang SM, Yan ST, Wei CK, et al. Solitary concomitant endocrine tumor and ductal adenocarcinoma of pancreas. World J Gastroenterol. 2010;16:2692–7.CrossRef Chang SM, Yan ST, Wei CK, et al. Solitary concomitant endocrine tumor and ductal adenocarcinoma of pancreas. World J Gastroenterol. 2010;16:2692–7.CrossRef
13.
Zurück zum Zitat Aoyama H, Yuasa N, Takeuchi E, et al. Collision tumor of ductal adenocarcinoma and neuroendocrine tumor of the pancreas. Jpn J Gastroenterol Surg. 2016;49:115–21.CrossRef Aoyama H, Yuasa N, Takeuchi E, et al. Collision tumor of ductal adenocarcinoma and neuroendocrine tumor of the pancreas. Jpn J Gastroenterol Surg. 2016;49:115–21.CrossRef
14.
Zurück zum Zitat Terashi T, Ljichi H, Maruyama S, et al. A case of collision carcinoma of the pancreas: invasive ductal carcinoma and endocrine carcinoma. Jpn J Gastroenterol Surg. 2010;43:66–71.CrossRef Terashi T, Ljichi H, Maruyama S, et al. A case of collision carcinoma of the pancreas: invasive ductal carcinoma and endocrine carcinoma. Jpn J Gastroenterol Surg. 2010;43:66–71.CrossRef
15.
Zurück zum Zitat Chatelain D, Parc Y, Christin-Maitre S, et al. Mixed ductal pancreatic polypeptide-cell carcinoma of the pancreas. Histopathology. 2002;41:122–6.CrossRef Chatelain D, Parc Y, Christin-Maitre S, et al. Mixed ductal pancreatic polypeptide-cell carcinoma of the pancreas. Histopathology. 2002;41:122–6.CrossRef
16.
Zurück zum Zitat Ballas KD, Rafailidis SF, Demertzidis C, et al. Mixed exocrine-endocrine tumor of the pancreas. JOP. 2005;6:449–54.PubMed Ballas KD, Rafailidis SF, Demertzidis C, et al. Mixed exocrine-endocrine tumor of the pancreas. JOP. 2005;6:449–54.PubMed
17.
Zurück zum Zitat de Mestier L, Cros J, Neuzillet C, et al. Digestive system mixed neuroendocrine-non-neuroendocrine neoplasms. Neuroendocrinology. 2017;105:412–25.CrossRef de Mestier L, Cros J, Neuzillet C, et al. Digestive system mixed neuroendocrine-non-neuroendocrine neoplasms. Neuroendocrinology. 2017;105:412–25.CrossRef
18.
Zurück zum Zitat Araki K, Shimura T, Kobayashi T, et al. Mixed ductal-endocrine carcinoma of the pancreas occurring as a double cancer: report of a case. Int Surg. 2011;96:153–8.CrossRef Araki K, Shimura T, Kobayashi T, et al. Mixed ductal-endocrine carcinoma of the pancreas occurring as a double cancer: report of a case. Int Surg. 2011;96:153–8.CrossRef
Metadaten
Titel
Collision of a pancreatic ductal adenocarcinoma and a pancreatic neuroendocrine tumor associated with multiple endocrine neoplasm type 1
verfasst von
Akihisa Ohno
Nao Fujimori
Masami Miki
Takamasa Oono
Hisato Igarashi
Ryota Matsuda
Yutaka Koga
Yoshinao Oda
Takao Ohtsuka
Masafumi Nakamura
Tetsuhide Ito
Yoshihiro Ogawa
Publikationsdatum
20.09.2020
Verlag
Springer Singapore
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 1/2021
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-020-01234-0

Weitere Artikel der Ausgabe 1/2021

Clinical Journal of Gastroenterology 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.